Approvals/TGA/HIZENTRA AU Human Normal Immunoglobulin 20% Solution for Subcutaneous Injection 50 mL vial

Approved

STANDARD

HIZENTRA AU Human Normal Immunoglobulin 20% Solution for Subcutaneous Injection 50 mL vial

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ae0b3cb1daf3cf4f
Product Name: HIZENTRA AU Human Normal Immunoglobulin 20% Solution for Subcutaneous Injection 50 mL vial
Artg Id: 328609
Artg Name: HIZENTRA AU Human Normal Immunoglobulin 20% Solution for Subcutaneous Injection 50 mL vial
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2020-07-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ae0b3cb1daf3cf4f

Type

Standard